Stools
PreclinicalBiologic
Stools is one of 49 biologic programs targeting Clostridium Difficile Infection. It is currently in Preclinical.
2
Indications
2
Total Trials
0
Active Trials
48
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
1931 competitors in COVID-19
#DrugCompanyPhaseTrials
1Bnt162b2
BioNTechPreclinical
COVID-19 Vaccine
ModernaPreclinical
Stivarga
BayerPreclinical
Activella
Eli LillyPreclinical
Benadryl
PParkedale
Preclinical
HB-Admscs
HHope Biosciences Research Foundation
Preclinical
Aprotinin
BayerPreclinical
Olokizumab
UCBPreclinical
Interferon-Gamma
SSPP Pharmaclon Ltd.
Preclinical
MRNA COVID-19 Vaccine
NovartisPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Stools. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- VVersailles Hospital